Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health

Mar.12
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health

Partner Content

Content provided by 【GFN】

 

Registration is now open for the 13th annual Global Forum on Nicotine (GFN26), taking place from Wednesday 3 to Friday 5 June at The Warsaw Presidential Hotel in Warsaw, Poland. Themed Prohibition and public health, this year’s event will examine a deep structural contradiction emerging between science and global public health policy.

 

Despite causing millions of deaths each year, combustible cigarettes remain universally and legally available. Meanwhile, far lower-risk nicotine products – nicotine vapes, pouches, heated tobacco products or Swedish-style snus – are facing blanket or partial bans in many countries. Nicotine does not cause the cancers, cardiovascular disease and respiratory illnesses associated with smoking; these are driven by the toxic byproducts of combustion. Alternative products deliver nicotine without burning tobacco, significantly reducing exposure.

 

 

Regulation, not prohibition

 

 

Effective regulatory frameworks balance the concern over prevention of youth uptake with the huge opportunities to reduce the global burden of death and disease caused by a billion adults who smoke. Yet prohibitive or restrictive policies are endorsed by influential global institutions such as the World Health Organization, justified as being for the ‘protection’ of public health.

 

This directly contradicts years of large-scale epidemiological evidence demonstrating that safer nicotine products reduce smoking rates. In countries where safer products are accessible and affordable, such as Sweden, Norway, the United Kingdom, New Zealand and Japan, cigarette sales have declined much more rapidly, as millions switch away from smoking to safer options.

 

Even as the science-base in support of tobacco harm reduction’s role in public health strengthens, it seems the opposition to safer nicotine products intensifies. GFN26 will critically examine the ways in which prohibition is jeopardising public health goals by entrenching cigarette use, fuelling illicit tobacco and nicotine markets and undermining global efforts to reduce smoking-related disease.

 

The programme will feature keynote addresses, panel discussions and interactive workshops, alongside the return of GFN’s popular Science Lab. Panels and keynote will address:

  • The health, wellbeing and ethical implications of prohibition;
  • The economic impact of prohibition;
  • The unintended consequences of prohibition on illicit markets and organised crime.

 

Jessica Harding, Conference Director, GFN26, said:

 

“Prohibition is increasing at a time when innovation offers unprecedented opportunities to accelerate the end of smoking. Nicotine consumers are paying the price. Unable to access regulated products, millions are forced to choose: either risk using unregulated or illicit nicotine products, or return to deadly tobacco. When cigarettes remain on sale everywhere and safer alternatives are banned or heavily restricted, who is really being protected?”

 

 

An inclusive global platform

 

 

Established in 2014, the Global Forum on Nicotine is the only international conference dedicated to the role of safer nicotine products in helping people move away from smoking.

 

Its open-door, multi-stakeholder approach is unique, welcoming consumers who have switched from smoking, public health professionals, researchers, policymakers, regulators, parliamentarians, manufacturers and media representatives. Many of these groups are either excluded or siloed in other international forums.

 

Speakers and delegates will debate how best to promote evidence-based policy in an environment where harm reduction is frequently portrayed as industry-driven or inherently suspect. By fostering dialogue across sectors, GFN aims to advance practical solutions to reduce smoking-related harm.

 

Affordably priced, GFN26 is a hybrid event. Accommodation at The Warsaw Presidential can be booked at a discounted rate until Monday 4 May. Selected sessions will be streamed live free of charge and simultaneously translated into Spanish and Russian, widening access, and the conference’s broadcast arm, GFN•TV, will again provide live commentary.

 

Opportunities for community participation include the GFN Fives – short, five-minute video contributions published online – and the return of Science Lab, where researchers present emerging findings to an international audience. GFN is open to everyone with an interest in the future of tobacco and nicotine policy – join the event and make your voice heard.

 

In 2026, 2Firsts will continue to serve as an official media partner of GFN, delivering the latest coverage to readers worldwide.

 

GFN 2025
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.
Jul.16
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT-owned nicotine pouch brand VELO and the McLaren Mastercard Formula 1 Team have launched a global fan engagement campaign offering motorsport enthusiasts opportunities to win exclusive team-related experiences. The initiative aims to connect racing culture, fan interaction and VELO’s brand experience across global markets. The partnership reflects BAT’s broader strategy of expanding modern nicotine product brands beyond traditional tobacco categories through lifestyle and cultural marketing.
Jul.23
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Nearly Half of Seoul Vape Vending Machines Bypassed by Fake IDs, Raising Youth Access Concerns
Seoul city authorities inspected 339 tobacco vending machines at e-cigarette retailers and found that 168, or 49.5%, allowed purchases using fake IDs, showing that unmanned retail terminals and adult-verification systems remain a major enforcement gap after e-cigarettes were brought under tobacco regulation.
Market
Jul.03 by 2Firsts Perspectives